Gabriel Mircus
Impact in
- Modeling and Simulation top 1%
- COVID-19 epidemiological studies
- Health top 1%
- Vaccine Coverage and Hesitancy
Papers in
-
- SARS-CoV-2 and COVID-19 Research 5
- Antifungal resistance and susceptibility 5
- SARS-CoV-2 detection and testing 2
- Health 5
- Vaccine Coverage and Hesitancy 5
- Co-authors
- John M. McLaughlin (5 shared papers)Eric J. Haas (5 shared papers)David L. Swerdlow (5 shared papers)Yeheskel Levy (5 shared papers)Luis Jódar (5 shared papers)Shepherd Roee Singer (5 shared papers)Kaijie Pan (5 shared papers)Sharon Alroy‐Preis (5 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (2 papers)IEEE Transactions on Biomedical Engineering (1 paper)Scientific Reports (1 paper)Clinical Microbiology and Infection (1 paper)ChemNanoMat (1 paper)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Gabriel Mircus
14 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Modeling and Simulation 335
- Health 531
- Infectious Diseases 1.0k
- Obstetrics and Gynecology 58
- Animal Science and Zoology 66
Countries citing papers authored by Gabriel Mircus
This map shows the geographic impact of Gabriel Mircus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Mircus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Mircus more than expected).
Fields of papers citing papers by Gabriel Mircus
This network shows the impact of papers produced by Gabriel Mircus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Mircus. The network helps show where Gabriel Mircus may publish in the future.
Co-authors
The 25 scholars most cited alongside Gabriel Mircus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data Hit paper breakdown → | 2021 | 1042 |
| 2 | 2021 | 79 | |
| 3 | 2011 | 27 | |
| 4 | 2017 | 25 | |
| 5 | 2016 | 23 | |
| 6 | 2016 | 22 | |
| 7 | 2021 | 19 | |
| 8 | 2008 | 18 | |
| 9 | 2018 | 18 | |
| 10 | 2015 | 17 | |
| 11 | 2009 | 12 | |
| 12 | 2018 | 8 | |
| 13 | 2021 | 6 | |
| 14 | 2021 | 2 | |
| 15 | 2024 | 0 | |
| 16 | 2025 | 0 |
About Gabriel Mircus
Gabriel Mircus is a scholar working on Infectious Diseases, Health, Molecular Biology, Epidemiology and Pharmacology, having authored 16 papers that have together received 1.3k indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Antifungal resistance and susceptibility (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), SARS-CoV-2 detection and testing (2 papers), Pneumonia and Respiratory Infections (2 papers), Respiratory viral infections research (2 papers) and Advanced biosensing and bioanalysis techniques (1 paper). The work is most often cited by research in Modeling and Simulation (335 citations), Health (531 citations), Infectious Diseases (1.0k citations), Obstetrics and Gynecology (58 citations) and Animal Science and Zoology (66 citations). Gabriel Mircus has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include John M. McLaughlin, Eric J. Haas, David L. Swerdlow, Yeheskel Levy, Luis Jódar, Shepherd Roee Singer, Kaijie Pan, Sharon Alroy‐Preis, Frederick J. Angulo and Emilia Anis. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, IEEE Transactions on Biomedical Engineering, Scientific Reports, Clinical Microbiology and Infection and ChemNanoMat.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.